73969-8

LOINC 2.82

Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA

Fet Ts 13 risk Plas.cfDNA Qn

Definition

  • The probability risk for trisomy 13 can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal sex chromosome aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.

Component

  • Fetal trisomy 13 risk

Specimen / system

  • Plas.cfDNA

Class

  • MOLPATH.TRISOMY

Property

  • Likelihood

Scale

  • Qn

Method

  • Dosage of chromosome specific cf DNA

Related names

  • Chromosom; Chromosomes; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Patau syndrome; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Spec; Ts; Ts 13 risk

Index terms

  • Chromosom
  • Chromosomes
  • Genetics
  • Heredity
  • Heritable
  • Inherited
  • Molecular pathology
  • MOLPATH
  • MOLPATH.TRISOMY
  • Patau syndrome
  • Pl
  • Plasma
  • Plsm
  • Point in time
  • QNT
  • Quan
  • Quant
  • Quantitative
  • Random
  • Risk
  • Spec
  • Ts
  • Ts 13 risk